The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca
Koray Gumus1, Dwight H Cavanagh21Department of Ophthalmology, Erciyes University School of Medicine, Kayseri, Turkey; 2Department of Ophthalmology, The University of Texas Southwestern Medical Center, Dallas, Texas, USAPurpose: To review and integrate recent advances in identifying the role of infla...
Guardado en:
Autores principales: | Koray Gumus, Dwight H Cavanagh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bd92114979c3481aad1da6db9c5a1237 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of patients with keratoconjunctivitis sicca with Optive™: results of a multicenter, open-label observational study in Germany
por: Thomas Kaercher, et al.
Publicado: (2008) -
A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca
por: Jerkins GW, et al.
Publicado: (2020) -
Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca
por: Sheppard J, et al.
Publicado: (2021) -
Listeria monocytogenes endophthalmitis following keratoconjunctivitis
por: Shoughy SS, et al.
Publicado: (2014) -
Vernal keratoconjunctivitis
por: Addis H, et al.
Publicado: (2018)